Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
It was found that this combination reduced hepatic steatosis and inflammation through FXR-related pathways
Retatrutide (LY3437943) is an engineered 39-amino-acid peptide designed for targeted interaction across three distinct peptide hormone receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon (GCG) receptor
They just dont want it anymore
In a study of adipose mass, growth therapy treatment for 26 weeks resulted in: Subcutaneous fat mass decreased by 13% Intra-abdominal fat mass reduced by 30% Lean body mass increased by 3-11% Aerobic function improved by 11-19% Muscle strength increased by 7-19% These changes continued during one year of treatment resulting in a 22% reduction in overall fat mass and a 61% reduction in belly fat
US$ 22.65
US$ 21.82
/media/img/mt/2026/07/PeptideGoldRush/original.png){kind=icon}
US$ 25.30
US$ 27.39
US$ 27.88
US$ 24.66
US$ 25.33
